- FTSE 100 index drops 46 points
- Housebuilders defy the trend
- Burberry marked lower after a coronavirus update
11.15am: Losses pared as sterling ebbs
Eary losses have been pared with the appeal of Footsie stocks burnished by sterlings weakening against the US dollar.
Sterling was down by around a sixth of a cent against the greenback.
The FTSE 100 was down 46 points (0.8%) at 5,780, with around a quarter of the indexs constituents in positive territory.
Among those defying the trend are housebuilders such as Barratt Developments PLC (LON:BDEV), up 1.3% at 522.6p, and Taylor Wimpey PLC (LON:TW.), up 0.9% at 149.1p, after the latter said yesterday it would start reopening some building sites.
Faring worse than the trend, however, was fashion firm Burberry Group PLC (LON:BRBU), which was down 3.0% at 1,300p after it said it would not rely on government support for jobs in the UK where more than a third of its employees are based.
UPDATE: British fashion house @Burberry has now donated more than 100,000 pieces of PPE to frontline healthcare workers. Gowns for the NHS are made at its trench coat factory in Castleford and masks have been sourced from its supply chain https://t.co/FRChXqOW10 #UKmfg #GBmfg????????
— Jefferson (@Jefferson_MFG) April 24, 2020
9.50am: Blue-chips stabilise after weak start
Aerospace stocks are prominent among the losers this morning as traders come to terms with the prospect of the lockdown lasting longer than hoped.
Drugs giant AstraZeneca PLC (LON:AZN) was lower but outperforming the Footsie after it announced further positive results from the Phase III PROfound trial of Lynparza (olaparib) in men with metastatic castration-resistant prostate cancer.
The shares were down 0.6% at 8,135p.
— BSMG and FLFO (@FlfoLinda) April 24, 2020
The company said it would pay its final dividend for last year, as a rise in online learning in the first quarter during the coronavirus pandemic has been offset by the closure of its test centres.
8.40am: Friday jitters
The FTSE 100 index fell back in early trade on Friday following a record drop in UK sales and after hopes for a coronavirus treatment were dashed.
The index of UK blue-chips opened 86 points lower at 5,740.75.
UK retail sales dropped by a record 5.1% in March – though analysts expect worse to come in the wake of the coronavirus (COVID-19) lockdown.
“Shops were already suffering before the coronavirus as a result of changing consumer behaviour. Increasing numbers of people are turning away from the high street and shopping online, which offers greater convenience and ease,” said Dr Kerstin Braun of Stenn Group, a trade finance provider.
“The COVID-19 pandemic has only escalated the decline of the high street and is likely to speed up these inevitable shifts, with high street footfall seeing its steepest decreases ever,” he added.
The retail sector was largely unfazed, however, with share prices of the industrys big hitters little changed in early exchanges.
Bombed out Marks & Spencer (LON:MKS) actually found some support from bargain hunters and nudged 2.3% higher.
The FTSE 100 opened sharply lower after the hopes a drug giant had found a coronavirus treatment were dashed. Gilead Sciences remdesivir was reported to have been successful in a small-scale trial; however, according to leaked papers, it failed in a larger Chinese deployment.
Not far behind were struggling airlines IAG (LON:IAG) and easyJet (LON:EZJ), down 4% and 3.6%, respectively, as hopes to an early end to the coronavirus lockdown receded. The farce around potentially having to leave the middle seat vacant when planes return to the air also added to the mix.
Proactive news headlines:
Scancell Holdings PLC (LON:SCLP) said it has begun a research programme to develop a vaccine for the coronavirus. The project, to be led by the companys chief scientific officer Lindy Durrant, will aim to utilise the companys clinical expertise in cancer to produce a cost-effective and scalable vaccine to induce both durable T-cell responses and virus neutralising antibodies against coronavirus. Initial research is now underway, with the company anticipating a phase 1 clinical trial in the first quarter of 2021.
SDX Energy PLC (LON:SDX) has confirmed successful well testing results at the recently drilled SD-12X (Sobhi) well, at the South Disouq project in Egypt. Sobhi flowed at a maximum rate of 25mln cubic feet of gas per day (on a 54/64" choke), in an initial one hour test, followed by stable rate of 15mln cubic feet per day over three hours (on a 28/64" choke) and 10mln over four hours (on 16/64"). The company said that following a review of data it anticipates the well will produce at an optimum stabilised rate of 10-12mln cubic feet per day.
Tekcapital PLC (LON:TEK) said its portfolio firm, Lucyd is to launch its range of Bluetooth-enabled glasses on the website of US superstore chain Walmart Inc (NYSE:WMT). The investment firm said the expansion offered a “new opportunity” to reach Walmarts customer base, which is estimated to make up about 6% of the entire US eCommerce sector. In a statement, Tekcapital said Lucyd is “aggressively expanding” its online direct-to-consumer presence, adding that the firm has also listed its flagship Loud 2020 glasses range on both the eBay marketplace and the Mercari selling app.
Genedrive PLC (LON:GDR) and Inspiration Healthcare Group PLC (LON:IHC) are collaborating to distribute Genedrives antibiotic-induced hearing loss (AIHL) test in the UK & Ireland. The companies also expect to expand the scope of the contract over time to engage Inspiration Healthcare's network of more than 50 neonatal-focused sub-distributors around the world. The Genedrive MT-RNR1 AIHL test is the world's first point-of-care genetic test designed for use in a neonatal intensive care setting. The test screens newborns for a genetic mutation called mt-RNR1 that can cause lifelong and irreversible deafness to a child upon administration of certain antibiotics.
i3 Energy PLC (LON:I3E) has told investors that it is in talks with its loan note holders to get consent to waive a condition which would require new funding to be in place by the end of this month. In a statement, the company noted that a November 2019 extension demanded that i3E Energy, by April 30, entered a reserves-based lending facility or alternative financing to take the Liberator field. However, the group said: “As the company will not be in a position to enter into such a facility by April 30, the company is in discussions with all noteholders to waive this condition and expects to provide an update to the market prior to April 30.”
Tiziana Life Sciences PLC (NASDAQ:TLSA) (LON:TILS) has carried out a little corporate housekeeping by issuing shares to retire a chunk of debt. It has wiped out £1.595mln of convertible loan notes, including accrued interest. At the same time, warrants were exercised bringing in just under £600,000 to the business. In the same announcement investors, were told AIM-listed Tizianas plans to redomicile to Bermuda, cancel its American Depositary Receipt (ADR) programme and have its Bermuda common shares listed on NASDAQ have been delayed. It cited the coronavirus lockdown and “other factors” for the hold-up.
Landore Resources Ltd (LON:LND) said it has raised gross proceeds of £260,000 in an equity issue to support the funding of exploration activities and working capital. Some 38.5mln subscription securities – comprising one share and one share warrant – are being sold to new investors and existing shareholders at a price of 0.675p each. The 1p warrants are exercisable at any time over a 24 month period.
Pembridge Resources PLC (LON:PERE) has had to revise the share subscription announced on April 20 to ensure it is compliant with prospectus regulation rules and said certain directors have also agreed to surrender their options to maximise the amount of capital that can be raised in the placing. The group had been looking to issue 19,183,179 new ordinary shares to raise £633,000 under the original subscription but that exceeds the maximum amount permitted of 20% of its current issued share capital. It now intends to issue 11,175,499 new ordinary shares resulting in a revised subscription of £368,000 at the same price of 3.3p.
Galantas Gold Corporation (LON:GAL) (CVE:GAL), the gold producer and explorer with a 100% interest in Northern Ireland's Omagh gold mine, has said that it intends to rely on the Canadian Securities Administrators blanket relief as a result of the coronavirus (COVID-19) outbreak for its filings for the year ended December 31, 2019, which it now anticipates on or before June 12, 2020. The company added that it expects to be filing, before May 29, a short technical report in respect to a recent probe drilling campaign carried out underground at the Omagh mine. As disclosed on January 16, 2020, the group said the results of the campaign, combined with detailed mapping of the exposed mineralisation underground suggest zones of higher width of mineralisation within the vein, linking adjacent levels. Galantas said this supports a model that such zonal mineralisation may continue at depth, with enhanced exploration potential for targeting gold resources on-site and within the company's license area.
accesso Technology Group PLC (LON:ACSO), the premier technology solutions provider to leisure, entertainment and cultural markets, said its annual general meeting (AGM) will be held on Tuesday, May 19, 2020. It added that, given the need to observe the UK government's current guidance on social distancing as well as prohibiting all non-essential travel and public gatherings of more than two people, the AGM will be held at its company secretary's home office. The group said its board will ensure a quorum is present and no additional shareholders will be able to attend the meeting and it strongly encourages all shareholders to complete and return a proxy form to ensure all votes are included.
6.30am: Footsie set to open lower
Equities are to open lower in London as one of the hopes for a vaccine to treat the coronavirus (COVID-19) blew out in a trial.
Spread betting quotes indicate the FTSE 100 will open 108 points lower at 5,719.
Draft documents accidentally published by the World Health OrganizatiRead More – Source